Fernando C. Fervenza
Mayo Clinic(US)
Publications by Year
Research Areas
Renal Diseases and Glomerulopathies, Vasculitis and related conditions, Amyloidosis: Diagnosis, Treatment, Outcomes, Chronic Kidney Disease and Diabetes, Coagulation, Bradykinin, Polyphosphates, and Angioedema
Most-Cited Works
- → Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis(2010)2,684 cited
- → KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases(2021)2,273 cited
- → Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study(2012)1,404 cited
- → The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification(2009)1,221 cited
- → The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility(2009)1,032 cited
- → Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases(2021)748 cited
- →